Oliver Fairweather is Head of Multiple Sclerosis for Roche in the UK. Oliver has spent approximately half his career working in the field of MS. Roche is one of the world’s leading investors in pharmaceutical R&D and neurology is one of the company’s key areas of research.
Share This Speaker